Candriam S.C.A. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 142 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$502,000
-28.6%
500
-99.4%
0.00%
-62.5%
Q1 2020$703,000
-2.2%
82,2000.0%0.01%0.0%
Q4 2019$719,000
-70.1%
82,200
-63.2%
0.01%
-75.0%
Q3 2019$2,403,000
-14.9%
223,2000.0%0.03%
-8.6%
Q2 2019$2,824,000
+398.1%
223,200
+1427.3%
0.04%
+400.0%
Q1 2019$567,000
-91.9%
14,614
-95.8%
0.01%
-93.5%
Q4 2018$7,035,000
-51.5%
345,737
+9.3%
0.11%
-44.0%
Q3 2018$14,498,000
+133.4%
316,200
+201.1%
0.19%
+96.9%
Q2 2018$6,211,000
+34.2%
105,000
+54.4%
0.10%
+24.1%
Q1 2018$4,628,000
+14.2%
68,000
+65.9%
0.08%
+12.9%
Q4 2017$4,053,000
-41.1%
41,000
-28.7%
0.07%
-41.7%
Q3 2017$6,886,000
+60.8%
57,500
+17.3%
0.12%
+50.0%
Q2 2017$4,283,000
-25.5%
49,000
-68.3%
0.08%
-27.9%
Q1 2017$5,748,000
+71.0%
154,500
+41.1%
0.11%
+44.2%
Q4 2016$3,361,000
-26.3%
109,500
+61.0%
0.08%
-30.0%
Q3 2016$4,559,000
+66.3%
68,000
-26.1%
0.11%
+54.9%
Q2 2016$2,741,000
-13.9%
92,000
-15.6%
0.07%
-11.2%
Q1 2016$3,184,000
-51.8%
109,000
+29.3%
0.08%
-54.8%
Q4 2015$6,609,000
+45.4%
84,300
+39.8%
0.18%
+58.0%
Q3 2015$4,544,000
+34.2%
60,300
+107.9%
0.11%
+60.0%
Q2 2015$3,386,000
-15.7%
29,000
+70.6%
0.07%
-13.6%
Q1 2015$4,015,000
+51.5%
17,000
+21.4%
0.08%
+47.3%
Q4 2014$2,650,00014,0000.06%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,417,000$18,010,0002.24%
Palo Alto Investors LP 1,405,680$17,866,0000.87%
PFM Health Sciences, LP 2,838,376$36,076,0000.68%
TANG CAPITAL MANAGEMENT LLC 349,400$4,441,0000.60%
Capital Impact Advisors, LLC 127,029$1,615,0000.59%
Leap Investments LP 29,100$370,0000.50%
Spark Investment Management LLC 454,300$5,774,0000.40%
Partner Investment Management, L.P. 27,567$350,0000.37%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 262,945$3,342,0000.26%
Rock Springs Capital Management LP 534,400$6,792,0000.25%
View complete list of PUMA BIOTECHNOLOGY INC shareholders